Jason Slakter, MD
Dr. Slakter is an internationally recognized retinal disease specialist with over 29 years of experience in clinical practice. He created the Digital Angiography Reading Center (DARC), which is one of the largest centers for image evaluation for clinical trials of posterior segment disease with over 1,000 certified clinical sites in over 44 countries worldwide, serving as a key resource for industry-sponsored studies of new treatments for retinal disorders. Dr. Slakter is also a Clinical Professor of Ophthalmology at NYU School of Medicine and has published more than 100 papers and book chapters. Dr. Slakter serves as the Chief Executive Officer of Ohr Pharmaceutical, Inc. a pharmaceutical company focused on developing new therapeutics to meet unmet needs for a variety of ocular conditions.